Synthesis of HIV-1 Reverse Transcriptase Inhibitors
ISEF · 2019 Chemistry Third Award
Overview
Nowadays, the Human Immunodeficiency Virus type 1 (HIV-1) is treated by inhibitors of various types, especially substances able to block key stages of HIV life cycle. Within the last years, the most attention has been devoted to non-nucleoside reverse transcriptase inhibitors (NNRTIs), diarylpyrimidine (DAPY) derivatives in particular. Recently, it has been shown that carbonyl to hydrazone functionality replacement in DAPY derivatives led to significant increase in activity. With this objective in mind, a series of novel DAPY derivatives were proposed and synthesized by reacting the carbonyl compounds with hydrazine sulfate/amines. The reaction afforded the desired Schiff bases as well as unexpected byproducts. Hence, an efficient synthetic methodology towards novel DAPY derivatives has been developed. The series of synthesized anti-HIV inhibitors was tested against wild type and clinically relevant mutant HIV strains. All compounds were tested for their ability to inhibit replication of HIV-1 in infected MT-4 cells. Whereas starting carbonyl compound showed IC50 = 5.3 nM, the corresponding Schiff base possesses high nanomolar activity with IC50 = 2.2 nM. Methylene-linked byproduct, formed by reduction, displayed even higher inhibition activity with IC50 = 1.5 nM and diminished toxicity (CC50 = 42,167 nM). Based on this unexpected observation, the prochiral ketone was further reduced with hydride producing racemic alcohol, which showed comparable low nanomolar inhibition (IC50 = 5.0 nM). Pure enantiomers were subsequently separated using chromatography with chiral stationary phase; the (S)-enantiomer showed the lowest inhibition constant IC50 = 2.1 nM.
Awards (1)
- Third Award of $1,000 $1,000
Competition history
- ISEF 2019
Resources
Related projects
ISEF · 2018
Development of Synthesis Strategies of Quinoline for the Inhibition of HIV-Integrase
ISEF · 2022
Computational Design, Docking, and Analysis of Novel Aryl Sulfone Compounds as Potential NNRTIs
ISEF · 2019
Development of Integrase Inhibitors
ISEF · 2014
Novel Inorganic Metallacarborane Inhibitors of HIV-1 Protease
ISEF · 2026
Characterizing the Binding Affinity of Second-Generation HIV Maturation Inhibitors to Viral Protein Targets Using Solution NMR Spectroscopy
ISEF · 2017
A Novel Approach to Solve Target Mutation-Induced Drug Resistance for HIV-1 Fusion Inhibitors with the Hopfield Neural Network
ISEF · 2025
Novel Design and Total Synthesis of Aza-C-Nucleosides From Furfuryl Alcohol, the Key to Fighting RNA Viral Diseases
ISEF · 2017
Design, Synthesis and Bioevaluation of Novel Hydroxamic Acids Incorporating 2-Oxoindoline Moiety as Histone Deacetylase Inhibitors and Anticancer Agents
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair